Patents by Inventor Richard Mollard

Richard Mollard has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230181516
    Abstract: The present invention relates to the use of aminoacetonitrile derivatives (AADs) in the treatment of cancer and mTOR (mammalian Target of Rapamycin) pathway related diseases. In particular it relates to the use of AADs administered at particular dose amounts in order to achieve therapeutic effects.
    Type: Application
    Filed: May 11, 2021
    Publication date: June 15, 2023
    Applicant: PITNEY PHARMACEUTICALS PTY LIMITED
    Inventors: Roger ASTON, Richard MOLLARD
  • Publication number: 20050239201
    Abstract: The present invention relates to methods of inducing differentiation of stem cells into a specific cell lineage, preferably lung cells. In particular, the invention relates to in vitro methods of inducing differentiation of stem cells into a specific cell lineage. The invention also relates to methods of producing and recovering differentiated stem cells of a specific cell lineage. The invention also includes differentiated stem cells and cell lineages produced by the methods of the present invention. In one aspect of the present invention there is provided a method of inducing differentiation of a stem cell into a specific cell lineage, preferably lung cells, the method including: culturing a stem cell in vitro in the presence of a tissue sample and/or extracellular medium of a tissue sample, under conditions that induce differentiation of the stem cell into a specific cell lineage, wherein the differentiated stem cell is the same cell type as the tissue sample.
    Type: Application
    Filed: March 14, 2003
    Publication date: October 27, 2005
    Applicant: Monash University
    Inventors: Richard Mollard, Alan Trounson, Mark Denham
  • Publication number: 20020048580
    Abstract: The invention relates to a method of treating lung branching malformation in a subject by administering to the subject a pharmaceutically effective amount of a retinoic acid receptor (RAR) retinoid. The invention also relates to a method of increasing alveoli in a subject by administering a pharmaceutically effective amount of a retinoic acid receptor (RAR) antagonist. The invention further relates to a method of inducing primary lung bud formation in a subject by administering a pharmaceutically effective amount of a retinoic acid receptor agonist. The invention also relates to a method of identifying an agent capable of inducing primary lung bud formation, the method comprising: (a) administering an agent to an embryo; and (b) determining primary lung bud formation of said embryo.
    Type: Application
    Filed: June 7, 2001
    Publication date: April 25, 2002
    Applicant: Institut National De La Sante Et De La Recherche Medicale
    Inventors: Richard Mollard, Pierre Chambon, Manuel Mark